BioTek to be Awarded 2015 Governor’s Excellence in Worksite Wellness
News Feb 11, 2016
The award will be presented at the 2016 Worksite Wellness conference on March 30, 2016 in Burlington, VT. The conference highlights Vermont companies and their efforts to promote the health and wellness of employees. This year, Lilly Tarricone, Mark Boutin and Kathy Gendron at BioTek will be recognized for their leadership in BioTek’s BioFit wellness program.
BioTek’s continuing initiatives include a variety of activities, educational opportunities, generous health benefit premium incentives for participating employees, and other programs that appeal to their diverse workforce. The Company is also making strong strides in becoming a smoke-free campus by January 2017. Additionally, it sponsored a Fitbit® program, providing participating employees with free Fitbit devices to track activities and participate in virtual activity challenges as a group.
BioTek’s President and CEO, Briar Alpert, provided perspective, mentioning, “We collectively logged 200,000 miles on our Fitbits – this equates to over eight trips around the world, and is an amazing accomplishment that everyone can take pride in.”
“We’re pleased to note that our BioFit wellness program reaches beyond health and wellness benefits,” added Kathy Gendron, BioTek’s Vice President, Human Resources. “BioFit allows us to connect with each other, not just as colleagues, but as a family.”
PhoreMost and Plexxikon Collaborate to Identify Novel Drug TargetsNews
PhoreMost, the UK-based biopharmaceutical company dedicated to drugging ‘undruggable’ disease targets, today announced it has signed a collaborative agreement with Plexxikon Inc., the small molecule structure-guided R&D centre of Daiichi Sankyo.READ MORE
Lonza Opens World’s Largest Dedicated Cell-and-Gene-Therapy Manufacturing Facility in TexasNews
First-of-its-kind, state-of-the-art manufacturing facility with capacity to produce treatment for thousands of patients suffering from rare genetic disorders or life-threatening diseases.READ MORE
IONTAS and IGEM Therapeutics Collaborate to Identify Novel IgE AntibodiesNews
The project will add to IGEM’s pipeline of drugs and expand upon IGEM-F, an IgE targeting ovarian and other cancers, currently in a Phase 1/2a study.READ MORE
Comments | 0 ADD COMMENT
World Congress on Advanced Biomaterials and Tissue Engineering
Jun 20 - Jun 21, 2018